Response assessment for HCC patients treated with repeated TACE: The optimal time-point is still an open issue

J Hepatol. 2015 Dec;63(6):1530-1. doi: 10.1016/j.jhep.2015.07.031. Epub 2015 Aug 6.

Authors

Wenjun Wang¹, Yan Zhao¹, Wei Bai¹, Guohong Han²

Affiliations

¹ Department of Liver Disease and Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.
² Department of Liver Disease and Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China. Electronic address: [email protected].

PMID: 26256436
DOI: 10.1016/j.jhep.2015.07.031

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Carcinoma, Hepatocellular / therapy*
Chemoembolization, Therapeutic / methods*
Female
Humans
Liver Neoplasms / therapy*
Male